Loading...
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
Over three decades have passed since the first report on the expression of CA125 by ovarian tumors. Since that time our understanding of ovarian cancer biology has changed significantly to the point that these tumors are now classified based on molecular phenotype and not purely on histological attr...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4046138/ https://ncbi.nlm.nih.gov/pubmed/24886523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-13-129 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|